Fluocinonide

Fluocinonide

SCHEMBL2863286

CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C.C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO.C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NR3C1

The experimentally established mechanism targets of Fluocinonide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 known ✓ P04150 5/20 0.58
▸ HIF1A Q16665 10/20 0.58
▸ LMNA P02545 7/20 0.58
▸ PGR P06401 5/20 0.58
▸ AR P10275 3/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ CYP3A4 P08684 7/20 0.54
▸ MAPT P10636 3/20 0.54
▸ CNR1 P21554 2/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.54
▸ KCNH2 Q12809 1/20 0.54
▸ USP2 O75604 1/20 0.54
▸ HSD17B10 Q99714 3/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluocinonide SCHEMBL28122375 0.88 HIF1A (0.75) HIF1ALMNANR3C1PGRAR
Fluocinonide SCHEMBL3475945 0.88 HIF1A (0.75) HIF1ALMNANR3C1PGRAR
Betamethasone SCHEMBL3224067 0.85 NR3C1 (0.68) HIF1ALMNANR3C1PGRAR
Dexamethasone SCHEMBL3135309 0.85 NR3C1 (0.68) HIF1ALMNANR3C1PGRAR
Fluocinolone Acetonide SCHEMBL5501859 0.83 HIF1A (0.77) HIF1ALMNANR3C1PGRAR
Fluocinonide SCHEMBL11325670 0.82 HIF1A (0.82) HIF1ALMNANR3C1PGRAR
Fluocinonide SCHEMBL5664031 0.82 NR3C1 (0.62) HIF1ALMNANR3C1PGRAR
Amcinonide SCHEMBL2864339 0.81 HIF1A (0.74) HIF1ALMNANR3C1PGRAR
Betamethasone Acetate SCHEMBL3882689 0.81 HIF1A (0.71) HIF1ALMNANR3C1PGRAR
Fluocinonide SCHEMBL15568196 0.80 HIF1A (0.58) HIF1ALMNANR3C1PGRAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2253339-B1 A process for producing stents and corresponding stent SORIN BIOMEDICA CARDIO SRL (IT) 2011-12-28 — — EP disclosed
US-8084076-B2 Process for producing stents and corresponding stents SORIN BIOMEDICA CARDIO S.R.L. (IT) 2011-12-27 — — US disclosed
EP-2253339-A1 A process for producing stents and corresponding stent Sorin Biomedica Cardio S.r.l. (IT) 2010-11-24 — — EP disclosed
EP-1449546-B1 A process for producing stents and corresponding stent SORIN BIOMEDICA CARDIO SRL (IT) 2010-10-27 — — EP disclosed
US-20080140186-A1 PROCESS FOR PRODUCING STENTS AND CORRESPONDING STENTS SORIN BIOMEDICA CARDIO S.R.L. (IT) 2008-06-12 — — US disclosed
US-20040167612-A1 Process for producing stents and corresponding stents SORIN BIOMEDICA CARDIO S.R.L. (IT) 2004-08-26 — — US disclosed
EP-1449546-A1 A process for producing stents and corresponding stent SORIN BIOMEDICA S.p.A. (IT) 2004-08-25 — — EP disclosed
Send feedback